Skip to main content
Premium Trial:

Request an Annual Quote

NuGEN Hires James Stanchfield as Commercial Ops VP

NEW YORK, Nov. 12-NuGen Technologies has hired James Stanchfield as vice president of commercial operations, the company said yesterday.


Stanchfield will direct the company's efforts to commercialize its gene amplification technologies and expand its market share for genetic and proteomic analysis products.


He was previously executive vice president of marketing and business development at Arcturus Engineering in Mountain View, Calif.


NuGEN is a privately held tool company based in San Carlos, Calif.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.